Facial Diplegia in Guillain-Barre Syndrome
Author Information
Author(s): Nitin K Sethi, Josh Torgovnick, Edward Arsura, Alissa Johnston, Elizabeth Buescher
Primary Institution: Saint Vincent's Hospital and Medical Centers, New York, USA
Hypothesis
Is treatment necessary for patients with isolated facial diplegia and hyperreflexia, a variant of Guillain-Barre Syndrome?
Conclusion
Treatment may not be necessary for patients with isolated facial diplegia variant of Guillain-Barre Syndrome until the eighth day of illness.
Supporting Evidence
- The patient presented with facial diplegia and hyperreflexia but no motor weakness.
- Cerebrospinal fluid analysis showed normal glucose and elevated protein levels.
- Nerve conduction studies indicated partial denervation of facial nerves.
Takeaway
This study talks about a woman who had facial weakness but no other serious symptoms of Guillain-Barre Syndrome, suggesting that not all cases need treatment right away.
Methodology
Case report of a patient with facial diplegia and hyperreflexia, including clinical examination and treatment with IV immunoglobulin.
Potential Biases
Potential bias in treatment decision-making due to the subjective nature of clinical presentation.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 29-year-old right-handed Caucasian woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website